<DOC>
	<DOCNO>NCT01364441</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability ONO-2952 across ascend single dos healthy adult male female subject . The secondary objective characterize pharmacokinetic ( PK ) profile ONO-2952 . The tertiary objective study preliminarily evaluate effect meal upon PK profile ONO-2952 .</brief_summary>
	<brief_title>Single-Dose Study Evaluate Safety , Tolerability , Pharmacokinetics ONO-2952 Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy nonsmoking male female subject ( 1855 inclusive ) Body mass index ( BMI ) 1935 kg/m2 ( inclusive ) For female , surgically sterilize , postmenopausal , non lactate agree use double barrier method contraception History presence clinically significant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-2950</keyword>
	<keyword>healthy adult subject</keyword>
	<keyword>first human</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>